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An acidic variant form of arylsulfatase B from normal leukocytes and chronic myelogenous leukemia 
(CML) leukocytes was found to be phosphorylated at its serine and threonine residues through in vivo phos- 
phorylation with 32P,. However, the predominant phosphorylation site was serine in normal cells, in contrast 
to threonine in CML cells. A cyclic AMP-dependent protein kinase was responsible for phosphorylation 
of the sulfatase of CML cells. 
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1. INTRODUCTION 
A lysosomal arylsulfatase B enzyme catalyzes 
hydrolysis of the sulfate ester bond of N- 
acetylgalactosamine 4-sulfate at the non-reducing 
termini of glycosaminoglycans [l] and is a basic 
glycoprotein in itself [2]. We have reported that an 
acidic variant form (named Br) of arylsulfatase B, 
which was not detected in many normal tissues, 
was detected by anion-exchange chromatography 
in leukocytes from normal subjects and chronic 
myelogenous leukemia (CML) patients [3]. The 
amount of the variant was considerably greater in 
CML cells than in normal leukocytes. The anionic 
property of the Br variant was mainly due to 
phosphate groups bound to the carbohydrate 
moiety of arylsulfatase B [3]. Through in vivo 32P- 
labeling experiments, the Br enzyme of trans- 
plantable human lung tumor was shown to be 
phosphorylated on its protein moiety in addition to 
phosphorylation on the carbohydrate chains [4]. 
These observations indicate that the Br enzyme is 
a variant form of arylsulfatase B modified by 
* To whom correspondence should be addressed 
phosphorylation at both carbohydrate and protein 
moieties and suggest hat arylsulfatase B can be a 
substrate for a protein kinase. Protein phos- 
phorylation of lysosomal enzymes from normal 
cells is not known. This study was undertaken to 
define whether the arylsulfatase B variant from 
normal as well as CML leukocytes is phosphory- 
lated on its protein moiety. 
2. MATERIALS AND METHODS 
2.1. Materials 
Leukocytes from heparinized rvenous blood of 
healthy volunteers and CML patients were 
prepared separately by centrifugation using dex- 
tran [5]. Antiserum against human arylsulfatase B 
was prepared in rabbits immunized with the highly 
purified arylsulfatase B from normal human liver. 
The antiserum reacted with both human 
arylsulfatase B and Br enzymes from either normal 
or tumor tissues and cells, but not with 
arylsulfatase A [4]. The activity of arylsulfatase B 
was assayed using p-nitrocatechol sulfate as 
substrate, by the method of Baum et al. [6] with a 
slight modification. One unit of enzyme activity is 
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the amount of enzyme required to liberate 1 nmol 
p-nitrocatechol per h. 32Pi and [y-32P]ATP were 
obtained from New England Nuclear; CAMP- 
dependent protein kinase (from bovine heart) and 
alkaline phosphatase (from Escherichia coli) from 
Sigma; DEAE-cellulose (DE-52) and cellulose- 
coated thin-layer plates (10 x 10 cm) from What- 
man. All chemicals used were of reagent grade. 
2.2. In vivo isotopic labeling of leukocyte aryl- 
sulfatase 
Cells (5.7 x 10’ - 2.5 x 109) were preincubated 
in phosphate-free RPM1 1640 medium without an- 
tibiotics and calf serum at 37’C for 30 min in a 
5% CO2 chamber. 1 mCi 32Pi was then added and 
incubation pursued at 37°C for 20-24 h. Viability 
of cells after incubation was almost 100% as ex- 
amined by the standard trypan blue exclusion 
method. The 32P-labeled cells were homogenized in 
the absence of phosphatase inhibitor and cen- 
trifuged at 10 000 x g for 20 min. The supernatant 
was applied onto a PD-10 column (Pharmacia) 
equilibrated with 10 mM Tris-HCI, pH 7.5. The 
excluded fraction was applied onto a DE-52 col- 
umn (1.5 x 3.5 cm) equilibrated with the same 
buffer. B enzyme recovered in the effluent and BI 
enzyme eluted with 0.3 M NaCl in the same buffer 
were concentrated separately over an Amicon 
PM-lo, and immunoprecipitated as described [4]. 
The immuno complex was solubilized in 0.125 M 
Tris-HCl, pH 6.8, containing 1% SDS and 10 mM 
dithiothreitol, and an aliquot was assayed for 
radioactivity. 
2.3. Characterization of phosphorylated amino 
acids 
The ‘*P-labeled enzyme recovered in the im- 
muno complex was hydrolyzed with 6 M HCl at 
100°C for 4 h and subjected to two-dimensional 
separation on a thin-layer plate as in [4]. The la- 
beled phosphoamino acids were identified by co- 
separation using standard non-labeled phospho- 
amino acids detected by ninhydrin. 
2.4. In vitro phosphorylation of leukocyte aryl- 
sulfatase B by endogenous protein kinase 
Leukocytes were homogenized with 50 mM 
Hepes buffer, pH 6.8, and centrifuged at 500 x g 
for 10 min. The supernatant (0.3 ml, about 
600-2000 U arylsulfatase B activity) from either 
normal granulocytes or CML cells was sup- 
plemented with 10 mM NaF, 10 mM 
Mg(CHZ00)2, 0.25 mM EGTA, 0.1 mM 
isobutylmethylxanthine (BMX) and 20 PM 
[y-32P]ATP (2 x lo* cpm/nmol) in the presence or 
absence of 5 pM CAMP to a final volume of 1 ml. 
After 20 min at 3O”C, the reaction was terminated 
by 2 mM ATP, and the mixture was applied onto 
a PD-IO column equilibrated with 10 mM Tris- 
HCI, pH 7.5, and eluted with the same buffer. Fur- 
ther treatments were performed as described in sec- 
tion 2.2. 
2.5. In vitro phosphorylation of arylsulfatase B 
by CAMP-dependent protein kinase 
Arylsulfatase B purified (spec. act. 48 667 U/mg 
protein) from leukocytes was used as substrate for 
the protein kinase reaction. The incubation mix- 
ture (200 ~1) contained 876 U B enzyme, 20 /IM 
[y-32P]ATP (6.3 x lo5 cpm/nmol), 5 pg CAMP- 
dependent protein kinase, 0 or 5 pM CAMP, 10 
mM NaF, 10 mM Mg (CH3COO)2, 100/1M BMX, 
0.25 mM EGTA and 50 mM Hepes buffer, pH 6.8. 
Incubation was started by the addition of 
[y-32P]ATP and continued for 25 min at 3O”C, ter- 
minated and immunoprecipitated as described 
above. The radioactivity contained in the solubil- 
ized immunoprecipitate was determined and the 
product examined by 10% polyacrylamide gel elec- 
trophoresis (PAGE). In each phosphorylation ex- 
periment, duplicate determinations were made on 
two samples, and the average values are 
represented. 
2.6. Dephosphorylation of arylsulfatase B 
For this, the purified leukocyte arylsulfatase B 
(2900 U) was treated with 0.2 U alkaline 
phosphatase in 0.15 M Tris-HCl, pH 8.2, in 200~1 
for 16 h at 37°C. 
3. RESULTS 
3. I. Protein phosphorylation of arylsulfatase B1 
from normal and CML leukocytes 
Normal and CML leukocytes were incubated in 
the presence of [32P]orthophosphate. Arylsulfatase 
B and its acidic variant form, Bi, were separated 
on a DE-52 column, and purified using anti- 
arylsulfatase B antiserum. As shown in table 1, 
arylsulfatase Bi isolated from normal and CML 
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Table 1 a 
Phosphorylation of arylsulfatase Bi in normal and CML 
leukocytes 
Incorporation of 32P 
into Br (cpm/lO* cells) 
Normal leukocytes 2844 
CML leukocytes 8544 
leukocytes was significantly phosphorylated. 
Phosphorylation of the Br enzyme was higher in 
CML cells than in normal leukocytes under the 
conditions employed here. Phosphorylation of 
arylsulfatase B was low in normal and CML cells 
(not shown). Although the anionic property of the 
Br enzyme from CML cells [3] and lung tumor [7] 
was largely due to the highly phosphorylated car- 
bohydrate chains bound to the enzyme, the Br en- 
zyme from the tumor tissue was also 
phosphorylated on its protein [4]. Protein 
phosphorylation of the Br enzyme from leukocytes 
was examined through detection of phosphoamino 
acids from the 32P-labeled enzyme. As shown in 
fig.1, the enzyme protein of the Br enzyme from 
normal as well as CML leukocytes was 
phosphorylated at serine and threonine residues. 
However, the predominant phosphoamino acids 
were clearly different between normal and 
leukemic cells. Quantitation of the radioactivity in 
each spot revealed that phosphoserine represented 
60% of the total phosphoamino acids in the nor- 
mal leukocytes (fig.la), while threonine was 
predominantly (87%) phosphorylated in the CML 
leukocytes (fig. 1 b). 
3.2. Phosphorylation of arylsulfatase B and Bt 
by endogenous protein kinase in leukocytes 
To examine protein phosphorylation of the BI 
enzyme by endogenous protein kinase, leukocyte 
homogenates were incubated with [T-~~P]ATP in 
the presence or absence of CAMP. Significant in- 
corporation of phosphate was observed in the Bt 
enzyme from either normal cells or CML cells, 
while incorporation into the B enzyme from two 
sources was almost negligible (table 2). 
Phosphorylation of the Br enzyme in CML 
leukocytes was increased in the presence of CAMP. 
On the other hand, phosphorylation of the enzyme 
in normal leukocytes was essentially unaffected by 
Fig.1. Two-dimensional separation of the acid 
hydrolysates of radioactive arylsulfatase Br from 
leukocytes. 32P-labeled arylsulfatase Br was acid- 
hydrolyzed and subjected to two-dimensional separation 
on a thin-layer plate. lst, electrophoresis for 1000 V for 
1 h in CH#Z02H/HC02H/HzO (15 : 5 : 80, v/v, pH 1.9); 
2nd, chromatography in isobutyric acid/l M pyridine 
(5 : 3, v/v). The plate was fluorographed for 5-7 days at 
-80°C. (a) Normal leukocytes, (b), CML leukocytes. 
Ser-O-P, phosphoserine; Thr-O-P, phosphothreonine; 
0, origin; Pi, inorganic phosphate. 
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Table 2 
Phosphorylation of arylsulfatases B and Br enzymes in normal and CML 
leukocytes by endogenous protein kinase 
Incorporation of 32P (fmol/lOO U sulfatase) 
B enzyme Br enzyme 
CAMP (+) CAMP (-) CAMP (+) CAMP (-) 
Normal leukocytes ND ND 0.26 0.25 
CML leukocytes ND ND 0.21 0.11 
ND, not detected (c 0.01 fmol/lOO U sulfatase) 
Table 3 
Phosphorylation of arylsulfatase B from CML leukocytes by 
exogenous cyclic AMP-dependent protein kinase 
Incorporation of 32P into 
ASB (pmol/lOO U sulfatase) 
Native ASB, cyclic AMP ( + ) 4.2 
Dephosphorylated ASB, cyclic 
AMP (+) 6.5 
Native ASB, cyclic AMP (-) 0.65 
*ASB, arylsulfatase B 
November 1986 
0 
ASB-, - 
+ 
Fig.2. SDS-PAGE of the 32P-labeled arylsulfatase BI. 
Arylsulfatase Br phosphorylated by CAMP-dependent 
protein kinase was precipitated with anti-arylsulfatase B 
antiserum. The precipitate was electrophoresed ac- 
cording to Laemmli [lo]. ASB, migration position of 
purified arylsulfatase B; -, cathodic origin where the 
labeled materials were applied. 32P-labeled compound in 
the origin is considered to be an aggregate of 32P-ASB. 
the addition of CAMP, and the phosphorylation 
level was somewhat higher in normal leukocytes 
than in CML leukocytes. 
3.3. Phosphorylation of native and dephos- 
phorylated arylsulfatase B by exogenous 
CAMP-dependent protein kinase 
Since the addition of CAMP enhanced 
phosphorylation of the sulfatase from CML cells, 
phosphorylation can probably be attributed to a 
CAMP-dependent protein kinase. The purified 
arylsulfatase B served as a substrate for 
phosphorylation by the CAMP-dependent protein 
kinase of bovine heart. Maximum incorporation of 
32P from [Y-~‘P]ATP into the sulfatase was at- 
tained within 10 min. As shown in table 3, 
phosphorylation of the sulfatase was much 
enhanced by CAMP. On the other hand, the 
sulfatase which had been treated with alkaline 
phosphatase prior to the kinase reaction incor- 
porated 1.5-times more “P than the native 
arylsulfatase B. When the Bl enzyme served as a 
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substrate, the phosphorylated sulfatase was hardly 
detected. The phosphorylated arylsulfatase B 
behaved similarly to the native arylsulfatase B on 
SDS-PAGE (fig.2). The native B and Br enzymes 
from lung tumor could not be distinguished by 
SDS-PAGE [4]. 
These results provide evidence that arylsulfatase 
B from leukocytes is a substrate for the CAMP- 
dependent protein kinase. 
4. DISCUSSION 
In this study we demonstrated that the acidic 
variant form (Br) of arylsulfatase B from normal 
as well as CML leukocytes is phosphorylated in the 
protein moiety. The in vitro phosphorylation was 
stoichiometric, although stoichiometric analysis of 
in vivo phosphorylation of the sulfatase was dif- 
ficult due to the low amount of sulfatase available 
from the cultured cells. This is the first demonstra- 
tion that a lysosomal enzyme from normal cells is 
a phosphoprotein. Protein phosphorylation of 
lysosomal enzymes has been shown in arylsulfatase 
BI [4] and P-glucuronidase [S] from human 
tumors. However, the predominant sites of 
phosphorylation in leukocyte sulfatase by in vivo 
phosphate incorporation differ between normal 
and CML cells. This difference may relate to the 
observation that the sulfatase from normal cells 
was not affected by added CAMP in contrast to the 
significant effect of this nucleotide in CML cells by 
in vitro phosphorylation with endogenous protein 
kinase(s) (table 2). In addition to the difference in 
conditions between the in vivo and in vitro ex- 
periments, other explanations are possible for the 
above observations: (i) the concentration of CAMP 
is deficient in CML cells, (ii) there are differences 
in the level of adenylate cyclase activity or in the 
mode of action of cyclase modulation [9] in nor- 
mal and CML cells or, (iii) a CAMP-dependent 
protein kinase is responsible for phosphorylation 
of the sulfatase in CML cells whereas CAMP- 
independent kinase(s) may play a role in normal 
cells. 
Enzyme phosphorylation and dephosphoryla- 
tion play a major role in metabolic regulation. 
Since a fair amount of purified enzyme is required 
to examine this possibility, we studied this on the 
purified sulfatase from normal human liver, a 
tissue rich in lysosomal hydrolases. The liver 
sulfatase was found to possess a phosphorylation 
site for a CAMP-dependent protein kinase, and the 
sulfatase activity was enhanced about 50% upon 
phosphorylation (to appear elsewhere). 
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